Expertise in
44
conditions

Dr. Murray B. Gordon

Endocrinology
Allegheny Endocrinology Associates PC
420 E North Ave Ste 205, 
Pittsburgh, PA 
Expertise in
44
conditions
Allegheny Endocrinology Associates PC
420 E North Ave Ste 205, 
Pittsburgh, PA 

Overview

Murray Gordon is an Endocrinologist practicing medicine in Pittsburgh, Pennsylvania.

Dr. Gordon is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Acromegaly, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaloid Facial Appearance Syndrome, Hormone Replacement Therapy (HRT), and Thyroidectomy.

He is actively involved in clinical research, co-authoring 33 peer reviewed articles and participating in 10 clinical trials.

Specialties

Endocrinology

Licenses

Internal Medicine in PA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Allegheny Endocrinology Associates PC
420 E North Ave Ste 205, Pittsburgh, PA 15212

Additional Areas of Focus

Dr. Gordon has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism
Enrollment Status: Completed
Publish Date: July 14, 2026
Intervention Type: Other
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: June 19, 2025
Intervention Type: Drug
Study Drug: Levoketoconazole
Study Phase: Phase 3
Non-interventional Study for the Generation of Long Term Safety and Efficacy Data of Pasireotide s.c. in Patients With Cushing's Disease (Post-Authorization Safety Study)
Non-interventional Study for the Generation of Long Term Safety and Efficacy Data of Pasireotide s.c. in Patients With Cushing's Disease (Post-Authorization Safety Study)
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Drug
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Drug
Study Drug: LY3437943
Study Phase: Phase 2
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: November 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
Enrollment Status: Completed
Publish Date: May 29, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 6 Less Clinical Trials

33 Total Publications

Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years.
Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 03, 2026
Similar Doctors
Expertise in
8
conditions
Expertise in
8
conditions
Referral required

University Of Pittsburgh Physicians Department Of Medicine

3471 5th Avenue, Kaufmann Building Suite 1110, 
Pittsburgh, PA 
 (2.0 miles away)
412-648-6401
Languages Spoken:
English
See accepted insurances

Susan Greenspan, MD, is an internationally respected osteoporosis researcher whose specialties are the effects of osteoporosis in elderly women, and the assessment of new techniques to examine bone density and rate of bone loss and therapies to maintain bone health. Dr. Greenspan is very interested in educating the community and other physicians about osteoporosis. Dr. Greenspan is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Infertility, and Hypogonadism Primary Partial Alopecia. Dr. Greenspan is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine.

Expertise in
76
conditions
Dr. Hemlata Moturi
Endocrinology
Expertise in
76
conditions
Dr. Hemlata Moturi
Endocrinology
Referral required

Allegheny Endocrinology Associates PC

420 E North Ave Ste 205, 
Pittsburgh, PA 
 (0.1 miles away)
412-359-3426
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Hemlata Moturi is an Endocrinologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Moturi is highly rated in 76 conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Hypothyroidism, Obesity in Children, and Hashimoto Thyroiditis.

Expertise in
19
conditions
Dr. Pouneh K. Fazeli
Endocrinology
Expertise in
19
conditions
Dr. Pouneh K. Fazeli
Endocrinology
Referral required
Before you request

UPMC Center For Diabetes And Endocrinology

3601 5th Avenue, Falk Suite 3b, 
Pittsburgh, PA 
 (2.0 miles away)
412-586-9700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Pouneh Fazeli is an Endocrinologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Fazeli is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Amenorrhea, Pituitary Tumor, Hypothalamic Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Hormone Replacement Therapy (HRT). Dr. Fazeli is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Fazeli is currently accepting new patients.

Frequently Asked Questions about Dr. Murray B. Gordon

How do I make an appointment with Dr. Murray B. Gordon?

You can book an appointment with Dr. Murray B. Gordon by calling their office at 724-249-2753. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Murray B. Gordon a top-rated expert for Acromegaly?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Murray B. Gordon is classified as an Elite expert for Acromegaly, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Murray B. Gordon specialize in?

While Dr. Murray B. Gordon is a Endocrinology, they have specific expertise in Acromegaly, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, and Acromegaloid Facial Appearance Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Murray B. Gordon participate in research or clinical trials?

Yes. Dr. Murray B. Gordon has published 33 articles and abstracts on conditions like Acromegaly. You can view a list of Dr. Murray B. Gordon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Murray B. Gordon accept my insurance?

Dr. Murray B. Gordon accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 724-249-2753 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gordon's expertise for a condition
ConditionClose
View All 15 Distinguished Conditions
View All 24 Advanced Conditions
View All 34 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile